CKD Flashcards
Read some more in K&C about prevalence and staging of CKD - - -
List causes (in book) pg 775 of CKD under the following headings -
Congenital and inherited diseases
Glomerular disease
Vascular disease
Tubulointerstitial disease
Urinary tract obstruction.
Describe (from the book) the full progression of CKD
Inc the kidney nephrons, angiotensin 11 function
Proteinuria effect
What few factors does the prognosis of CKD correlate with + summarise the general therapy aims which slow the rate of CKD progression
Factors affecting prognosis -
Hypertension
Proteinuria
Histology (degree of scarring in interstitium, but not changes of glomeruli)
Therapy is aimed at:
.Inhibiting angiotensin II
.Reducing proteinuria (with ACEi/ ARBs
Describe why we get symptoms in CKD (referring to toxins - metabolic) and also refer to the accumulation of creatinine and urea … + when symptoms start to present
Early stages - fully asymptomatic, but later start to find symptoms
Symptoms thought to be as a result of the build of toxic metabolites (unknown, but thought to be nitrogen based).
Urea and creatinine are used as a surrogate for these metabolites as they are easy to measure, but we don’t know if they cause toxic themselves … (but correlation, increased creatinine with worsening condition)
Symptoms of CKD
Nausea/ Vom
Cachexia
Convulsions/ Faintings
Anaemia - tiredness
Bone pain
Confusion
Pruritus
Oedema symtpoms
Parasthesia - polyneuropathy
Nocturne - polyuria
Amenorrhea women
ED men
Remember that oliguria indicates more acute kidney injury, whereas in CKD tend to see polyuria etc after a while …
Read book (777) for what to look for on examination - - specific to uraemia and genitalia and kidney
List some investigations here, and go to book (777) and it explains what each is looking for specifically.
List 8 Here
Urinalysis
Urine microscopy
Urine biochemistry
Serum biochemistry
Haematology
Immunology
Radiological Investigation
Renal biopsy
List/ describe a few ways in which normocytic anaemia can develope in someone with CKD
EPO deficiency
Increased blood loss - GI, occult, haemodialysis loss …
Bone marrow toxins
Increased RBC destruction - cells have short life in uraemia
ACEi ‘ s
Describe in detail how we are managing anaemia In CKD with use of ESA’s
Erythropoiesis stimulating agents
Subcut/ IV
Start does 50U/Kg epoetin / day 3 times weekly
IV iron can be given prior.
Go to book to learn more about ESA’s inc what we are trying to achieve with them, the effects etc . . .
Go to the book to learn the target effects of treatment of anaemia in CKD
Read in book (779) about the pathogenesis of CKD mineral bone disorder
Can read how CKD can causes calciphylaxis, CVD, Skin disease, Gi comps, Metabolic abnormalities, Endo abnormalities and muscle dysfunciton